Soluble Urokinase Plasminogen Activator Receptor as a Decision Marker for Early Discharge of Patients with COVID-19 Symptoms in the Emergency Department

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (The Covid-19 pandemic) strains health care capacity. Better risk stratification, with discharge of patients with a predicted mild disease trajectory, can ease this burden. Elevated blood-soluble urokinase plasminogen activator receptor (su...

Descripción completa

Detalles Bibliográficos
Autores principales: Stauning, Marius Ahm, Altintas, Izzet, Kallemose, Thomas, Eugen-Olsen, Jesper, Lindstrøm, Mette Bendtz, Rasmussen, Line Jee Hartmann, Gamst-Jensen, Hejdi, Nehlin, Jan O., Andersen, Ove, Tingleff, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Clinical Laboratory Emergency Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997406/
https://www.ncbi.nlm.nih.gov/pubmed/34092446
http://dx.doi.org/10.1016/j.jemermed.2021.03.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997406/
https://www.ncbi.nlm.nih.gov/pubmed/34092446
http://dx.doi.org/10.1016/j.jemermed.2021.03.012

Ejemplares similares